Vaxxinity reports second quarter 2023 financial results and provides corporate update

Cape canaveral, fla., aug. 09, 2023 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx), a u.s. company pioneering the development of a new class of medicines, today reported financial results for the second quarter ended june 30, 2023, and provided a corporate update.

VAXX Ratings Summary

VAXX Quant Ranking